1. Home
  2. NXRT vs KMDA Comparison

NXRT vs KMDA Comparison

Compare NXRT & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NexPoint Residential Trust Inc.

NXRT

NexPoint Residential Trust Inc.

HOLD

Current Price

$17.70

Market Cap

469.4M

Sector

Real Estate

ML Signal

HOLD

Logo Kamada Ltd.

KMDA

Kamada Ltd.

SELL

Current Price

$7.96

Market Cap

460.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NXRT
KMDA
Founded
2014
1990
Country
United States
Israel
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
469.4M
460.3M
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
NXRT
KMDA
Price
$17.70
$7.96
Analyst Decision
Hold
Strong Buy
Analyst Count
6
3
Target Price
★ $25.25
$13.50
AVG Volume (30 Days)
★ 519.3K
67.3K
Earning Date
11-03-2026
11-09-2026
Dividend Yield
★ 11.54%
5.22%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $251,281,000.00
N/A
Revenue This Year
$2.06
$9.50
Revenue Next Year
$2.37
$12.63
P/E Ratio
★ N/A
$24.59
Revenue Growth
N/A
★ N/A
52 Week Low
$17.67
$6.55
52 Week High
$32.36
$9.35

Technical Indicators

Market Signals
Indicator
NXRT
KMDA
Relative Strength Index (RSI) 35.91 49.04
Support Level N/A $6.94
Resistance Level $20.22 $8.05
Average True Range (ATR) 0.66 0.20
MACD 0.10 0.02
Stochastic Oscillator 8.31 75.38

Price Performance

Historical Comparison
NXRT
KMDA

About NXRT NexPoint Residential Trust Inc.

NexPoint Residential Trust Inc is a real estate investment trust company. The trust's objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: